120
Views
0
CrossRef citations to date
0
Altmetric
Short Report

Effects of Caregiver Dementia Training in Caregiver–Patient Dyads on Psychotropic Drug Prescription: A Randomized Controlled Study

ORCID Icon, , ORCID Icon &
Pages 1449-1453 | Published online: 26 Jul 2021

References

  • Volksgezondheidenzorg.info. Bilthoven: RIVM; 2021. Available from: https://www.volksgezondheidenzorg.info/onderwerp/dementie/cijfers-context/huidige-situatie#node-aantal-personen-met-dementie-zorg. Accessed 512, 2021.
  • Centraal-Bureau-voor-de-Statistiek. Opendata.cbs.nl. the Hague: Centraal Bureau voor de Statistiek; 2021. Available from: https://opendata.cbs.nl/statline/#/CBS/nl/dataset/80117ned/table?ts=1555962502614. Accessed 512, 2021.
  • Ott A, Breteler MM, van Harskamp F, et al. Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. BMJ. 1995;310(6985):970–973. doi:10.1136/bmj.310.6985.9707728032
  • Borsje P, Wetzels RB, Lucassen PL, Pot AM, Koopmans RT. The course of neuropsychiatric symptoms in community-dwelling patients with dementia: a systematic review. Int Psychogeriatr. 2015;27(3):385–405. doi:10.1017/S104161021400228225403309
  • Zuidema SU, Smalbrugge M, Bil WME, et al. Multidisciplinairy guideline problem behaviour in Dementia [multidisciplinaire Richtlijn Probleemgedrag bij mensen met dementie]. Utrecht, The Netherlands: Verenso; 2018.
  • Joling KJ, Koppel MT, van Hout HPJ, et al. Psychotropic drug prescription rates in primary care for people with dementia from recorded diagnosis onwards. Int J Geriatr Psychiatry. 2021;36:443–451.33022804
  • Maust DT, Langa KM, Blow FC, Kales HC. Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA. Int J Geriatr Psychiatry. 2017;32(2):164–174. doi:10.1002/gps.445226889640
  • Orsel K, Taipale H, Tolppanen AM, et al. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer’s disease. Eur Neuropsychopharmacol. 2018;28(11):1260–1269. doi:10.1016/j.euroneuro.2018.04.00530153953
  • Clipp EC, George LK. Psychotropic drug use among caregivers of patients with dementia. J Am Geriatr Soc. 1990;38(3):227–235. doi:10.1111/j.1532-5415.1990.tb03496.x2313004
  • Martín-García R, Martín-Avila G, la Rubia-marcos MD, et al. Consumption of drugs and nonpharmacological therapies in caregivers of patients with Alzheimer’s disease: a case-control study in Madrid. Dement Geriatr Cogn Dis Extra. 2016;6(1):68–77. doi:10.1159/00044294227065471
  • Välimäki T, Gilmartin-Thomas JF, Bell JS, Selander T, Koivisto AM. Longitudinal study of medication use in caregivers of people with Alzheimer’s disease - Kuopio ALSOVA study. Dementia. 2020;19(5):1573–1585.30278783
  • Birkenhäger-Gillesse EG, Achterberg WP, Janus SIM, Kollen BJ, Zuidema SU. Effects of caregiver dementia training in caregiver-patient dyads: a randomized controlled study. Int J Geriatr Psychiatry. 2020;35(11):1376–1384. doi:10.1002/gps.537832662184
  • Birkenhager-Gillesse EG, Kollen BJ, Zuidema SU, Achterberg WP. The “more at home with dementia” program: a randomized controlled study protocol to determine how caregiver training affects the well-being of patients and caregivers. BMC Geriatr. 2018;18(1):252. doi:10.1186/s12877-018-0948-330348097
  • Birkenhäger-Gillesse EG, Achterberg WP, Janus SIM, Zuidema SU. Caregiver dementia training in caregiver-patient dyads: process evaluation of a randomized controlled study. Int J Geriatr Psychiatry. 2021;36(1):127–135. doi:10.1002/gps.540433411391
  • World-Health-Organization. Anatomical therapeutic classification. Geneva; 2020. https://www.who.int/toolkits/atc-ddd-toolkit. Accessed 206, 2021.
  • Birkenhäger-Gillesse EG, Kollen BJ, Achterberg WP, Boersma F, Jongman L, Zuidema SU. Effects of psychosocial interventions for behavioral and psychological symptoms in dementia on the prescription of psychotropic drugs: a systematic review and meta-analyses. J Am Med Dir Assoc. 2018;19(3):276.e271–276.e279. doi:10.1016/j.jamda.2017.12.100
  • Borsje P, Lucassen P, Wetzels RB, Pot AM, Koopmans R. Neuropsychiatric symptoms and psychotropic drug use in patients with dementia in general practices. Fam Pract. 2018;35(1):22–28. doi:10.1093/fampra/cmx06128985387